日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exploratory study reveals far reaching systemic and cellular effects of verapamil treatment in subjects with type 1 diabetes

探索性研究揭示了维拉帕米治疗对1型糖尿病患者的深远全身性和细胞性影响

Xu, Guanlan; Grimes, Tiffany D; Grayson, Truman B; Chen, Junqin; Thielen, Lance A; Tse, Hubert M; Li, Peng; Kanke, Matt; Lin, Tai-Tu; Schepmoes, Athena A; Swensen, Adam C; Petyuk, Vladislav A; Ovalle, Fernando; Sethupathy, Praveen; Qian, Wei-Jun; Shalev, Anath

Serum miR-204 is an early biomarker of type 1 diabetes-associated pancreatic beta-cell loss.

血清 miR-204 是 1 型糖尿病相关胰岛 β 细胞丢失的早期生物标志物

Xu Guanlan, Thielen Lance A, Chen Junqin, Grayson Truman B, Grimes Tiffany, Bridges S Louis Jr, Tse Hubert M, Smith Blair, Patel Rakesh, Li Peng, Evans-Molina Carmella, Ovalle Fernando, Shalev Anath

Verapamil and beta cell function in adults with recent-onset type 1 diabetes

维拉帕米对近期发病的1型糖尿病成人患者β细胞功能的影响

Ovalle, Fernando; Grimes, Tiffany; Xu, Guanlan; Patel, Anish J; Grayson, Truman B; Thielen, Lance A; Li, Peng; Shalev, Anath